NCT02373293View on ClinicalTrials.gov

Study to Assess the Prognostic Value of the Antithrombin III in the Acute Pancreatitis (AT-PROPANC)

UnknownOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

January 18, 2015

Primary Completion Date

January 30, 2015

Study Completion Date

August 31, 2017

Conditions
Acute Pancreatitis
Trial Locations (2)

08208

RECRUITING

Corporació Sanitària Parc Taulí, Sabadell

08970

RECRUITING

Hospital de Sant Joan Despí Moisés Broggi, Sant Joan Despí

Sponsors

Collaborators (1)

Alclinical Research, S.L.
All Listed Sponsors
collaborator

Alclinical Research, S.L.

UNKNOWN

lead

Francisco Javier García Borobia

OTHER

NCT02373293 - Study to Assess the Prognostic Value of the Antithrombin III in the Acute Pancreatitis (AT-PROPANC) | Biotech Hunter | Biotech Hunter